top glp-1 medication brands 2025 Pharma's Top-Selling Drugs in Q1 2025: Oncology, Immunology, and | Pharmint posted on the topic GLP-1 Shortage = Over -

despite what the advertising world has to say!

This week, we will discuss the blockbuster trial of 2024, FLOW

Featuring a powerful GLP-1 formula, this product is perfect for those looking to maintain overall well-being

3) validates their functional relevance in beta cells

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated

It's a fillip for new Novo Nordisk chief executive Mike Doustdar, who took the helm last year with a clear remit to defend the GLP-1-based weight loss and diabetes business from rivals like Eli Lilly, as well as knock-off versions of semaglutide that sidestep the company's intellectual property (IP).